DO

Doxa ABFNSE Doxa Stock Report

Last reporting period 31 Dec, 2023

Updated 15 Oct, 2024

Last price

Market cap $B

0.14

Micro

Exchange

FNSE - First North Sweden

DOXA.ST Stock Analysis

DO

Uncovered

Doxa AB is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

79/100

Moderate score

Market cap $B

0.14

Dividend yield

Shares outstanding

295.09 B

Doxa AB engages in the development, manufacture, and commercialization of bioceramic dental products. The company is headquartered in Malmo, Skane. The company went IPO on 2014-04-07. The firm develops, manufactures and commercializes products based upon its technology platform of calcium aluminate hydrate and bioactive ceramics. Activities are divided into the therapy areas of orthopedics and odontology. Research areas within orthopedics are methods for treating fractures resulting from osteoporosis, reconstructive orthopedics and coating of implants. Research areas within odontology are tooth restoration and implant fixation.

View Section: Eyestock Rating